Package 69097-514-03

Brand: abacavir

Generic: abacavir
NDC Package

Package Facts

Identity

Package NDC 69097-514-03
Digits Only 6909751403
Product NDC 69097-514
Product ID 69097-514_cf84089d-b713-40b8-a815-b66f4119982e
Description

60 TABLET, FILM COATED in 1 BOTTLE (69097-514-03)

Marketing

Marketing Status
Marketed Since 2017-11-21
Brand abacavir
Generic abacavir
Sample Package No

Linked Drug Pages (1)

Abacavir ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "cf84089d-b713-40b8-a815-b66f4119982e", "openfda": {"unii": ["J220T4J9Q2"], "rxcui": ["242679"], "spl_set_id": ["0d791375-e311-41f9-87b8-940657e6318c"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (69097-514-03)", "package_ndc": "69097-514-03", "marketing_start_date": "20171121"}], "brand_name": "Abacavir", "product_id": "69097-514_cf84089d-b713-40b8-a815-b66f4119982e", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Analog [EXT]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "69097-514", "generic_name": "Abacavir", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abacavir", "active_ingredients": [{"name": "ABACAVIR SULFATE", "strength": "300 mg/1"}], "application_number": "ANDA078119", "marketing_category": "ANDA", "marketing_start_date": "20171121", "listing_expiration_date": "20261231"}